A carregar...
Effect of 8-Week Combination Therapy with an Extended-Release α(1)-Blocker (Bunazosin or Doxazosin) in Inadequate Responders to an Angiotensin II Antagonist (Valsartan) in Patients with Stage 1 or 2 Essential Hypertension
BACKGROUND: Given the favorable impact of α(1)-blockers on lipid and glucose metabolism, this study was designed to compare the efficacy of two extended-release α(1)-blockers (bunazosin and doxazosin) as an add-on treatment in subjects with stage 1 or 2 essential hypertension which was inadequately...
Na minha lista:
| Publicado no: | Zhonghua Minguo Xin Zang Xue Hui Za Zhi |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taiwan Society of Cardiology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4804956/ https://ncbi.nlm.nih.gov/pubmed/27122680 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|